peripheral-arterial-disease
(3)
Semler Scientific
One company, two ledgers: a five-minute artery test that scans for hidden vascular disease, and a corporate treasury that traded idle cash for Bitcoin.
PEDRA Technology
PEDRA Technology is a Singapore-based medical device company that built the PEDRA Xauron Perfusion System, the first device to deliver real-time, quantitative measurement of deep-tissue blood perfusion in the foot during vascular procedures. Aimed at physicians treating peripheral arterial disease (PAD) and critical limb threatening ischemia (CLTI), the laser-based, non-invasive system gives interventionalists objective feedback in the angio suite - where they have historically relied on subjective interpretation of X-ray images. The company raised a $4.7M Series A in 2020 and won FDA Breakthrough Device Designation in 2021.
Evident Vascular, Inc.
Evident Vascular is a San Jose-based medical device startup building an AI-powered intravascular ultrasound (IVUS) platform designed for peripheral vascular interventions. Founded in 2023 and led by CEO Howard Rosen, the company aims to fix the long-standing trade-off between image quality and clinical workflow that has limited IVUS adoption, targeting FDA 510(k) clearance ahead of a U.S. launch. It raised a $35M Series A from Vensana Capital and closed an undisclosed Series B in 2025.